Viaman Pharma Terminates Licensing Agreement With Shanghai Drug Maker

Guangzhou Viaman Pharmaceutical Co. has terminated a licensing agreement with Shanghai Pioneer Pharmaceutical Co. Ltd. for its antibacterial piperacillin sodium and sulbactam sodium compound, citing lack of payment, a top company official told Interfax.
Interfax